COMP <GO>
NEOV vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
NeoVolta Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NEOV 2
— TMO 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: NEOV
LAST: $2.16 (-6.09%) • MKT CAP: $135.7M
balance-sheet
11.21
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEOV VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEOV | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 9.30% | -44.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.26% | 2.40% | -5.66 | TMO | /fcf-yield <GO> |
| Operating Margin | -56.00% | 17.40% | -73.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | -59.70% | 15.10% | -74.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 3.90% | +176.10 | NEOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 11.21 | 4.50 | +6.71 | NEOV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.7 | 62.9 | -23.22 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $135.7M | $262.22B | -$262.08B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEOV REV | TMO REV | NEOV GROSS % | TMO GROSS % | NEOV FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.4M | $44.56B | 17.9% | — | -$4.4M | $6.29B |
| FY 2024 | $2.6M | $42.88B | 19.3% | — | -$1.0M | $7.27B |
| FY 2023 | $3.5M | $42.86B | — | — | -$2.1M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEOV // BETA —
TMO // BETA 0.94